The Runt-related transcription factor (RUNX) family, which has essential roles in neural development and differentiation through regulation of the tropomyosin-related kinase (Trk) family, also has both oncogenic and tumor suppressive roles in various malignant neoplasms through regulation of the p53 family. This evidence concerns the gene TP53 and cancer.